EYEPOINT, INC. (EYPT)
EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals
EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact SueWallSt
REPL UPCOMING DEADLINE: SueWallSt Alerts Replimune Group, Inc. Stockholders of Securities Class Action - Contact the Firm
Perma-Pipe Secures More Than $67 Million in New Orders in the Second Quarter of 2026